Skip to main content
ArticleOPEN ACCESS

NK cell destiny after haploSCT with PT-Cy

Blood
DOI: 10.1182/blood-2017-10-811117
0Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Russo et al provide important insights on the effect of posttransplantation cyclophosphamide (PT-Cy) on natural killer (NK) cell recovery and function after haploidentical allogeneic stem cell transplantation (haploSCT).

References Powered by Scopus

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Blood
1570Citations
N/AReaders
Get full text

Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: Challenging its predictive value

Blood
541Citations
N/AReaders
Get full text

Alternative donor transplantation after reduced intensity conditioning: Results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts

Blood
485Citations
N/AReaders
Get full text
View more at Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Peled, A., & Nagler, A. (2018, January 11). NK cell destiny after haploSCT with PT-Cy. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2017-10-811117

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

38%

Researcher 3

38%

Professor / Associate Prof. 2

25%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

67%

Biochemistry, Genetics and Molecular Bi... 2

17%

Pharmacology, Toxicology and Pharmaceut... 1

8%

Engineering 1

8%

Save time finding and organizing research with Mendeley

Sign up for free